Northwestern University Medical School
Chicago, Illinois 60611-3010
0 studies enrolling now · 31 studies all time
What they study most
ALS, Acute Liver Failure, Acute Liver Injury, Advanced Well-differentiated Neuroendocrine Tumors, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Arthritis, Rheumatoid, Castration Resistant Prostate Adenocarcinoma, Chronic Obstructive Pulmonary Disease, Coronary Arteriosclerosis, Crohn's Disease, Diabetes Insipidus
Studies at this site
- Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary — Completed
- PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies — Completed
- A Multi-Center Trial to Study Acute Liver Failure in Adults — Completed
- A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma — Stopped early
- Study of N-Acetylcysteine in Acute Liver Failure (ALF) — Stopped early
- ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study) — Completed
- Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen — Completed
- Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy — Stopped early
- Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients — Completed
- CATIE-Alzheimer's Disease Trial — Completed
- Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma — Completed
- Clinical Trial Ceftriaxone in Subjects With ALS — Completed
- Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma — Completed
- A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) — Completed
- Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
- Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
- Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-wave Myocardial Infarction by MRI — Completed
- Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy — Completed
- A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 — Completed
- PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Completed
- Parkinson's Research: The Organized Genetics Initiative — Completed
- Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients — Completed
- ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects — Completed
- A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis — Completed
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
- An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease — Completed
- Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) — Completed
- Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments — Completed
- Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 — Paused
- Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus — Completed